chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: Mild reaction reported on 5/28/21 to the 2nd Moderna COVID vaccine dose which was administered on 5/13/21. Patient reported mid-upper epigastric pain, axillary swelling on right side, bruising to index fingers and thumbs, felt more short of breath and fever up to 103.
Patients arm unaffected where injection was given but at least 8 inches below this the patient developed cellulitis. Treatment with prednisone and doxycycline. Cellulitis of left arm.
Vaccine administered from vial which was punctured on Feb 25th and stored in refrigerator; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered from vial which was punctured on Feb 25th and stored in refrigerator) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered from vial which was punctured on Feb 25th and stored in refrigerator). On 11-Mar-2021, PRODUCT STORAGE ERROR (Vaccine administered from vial which was punctured on Feb 25th and stored in refrigerator) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This report refers to a case of Product storage error for mRNA-1273, lot # unknown  with no associated Adverse Events.   Reporter did not allow further contact; Sender's Comments: This report refers to a case of Product storage error for mRNA-1273, lot # unknown  with no associated Adverse Events.
Joint pain in hands. No history. Continually getting worse now for 6 weeks. Going to seek medical appointment. Swollen lymph nodes under arms for 6 weeks. No history.
Headache 11/23-25. Sore throat 11/25-27. Fever 11/25, none 11/26 but fever 11/27-11/30. Malaise, loss of appetite, cough (minimal). ER 11/27 and 11/28. Office visits 11/27, 11/30.
Patient broke out in a rash at the injection site.Also has spread to the back and up to the neck
3 cc dose administered - drug error. 6 dose injection. Arm red, painful @ injection site.
Information has received from an office manager (also reported as administrator) referring to a male patient of unknown age. On 27-APR-2015 the patient was vaccinated with an expired dose of VARIVAX (Merck) (lot # J005253, expiration date 26-APR-2015; first dose, 0.5 ml) subcutaneously. No adverse effects were reported. This is one of several cases reported from the same reporter. Additional information has been requested.
On the evening of 5/11/2022, I went to bed with mild body aches and chills. The following day, on 5/12/2022, I had severe head congestion, a low-grade fever, extreme fatigue, chills, and body aches. I took an at-home test for COVID on 5/12/2022, and the result was positive. I also took a PCR test, which also yielded a positive result. I managed my symptoms with Tylenol. I consulted with my PCP via telehealth, and since I didn't feel like my symptoms were severe enough to possibly lead to hospitalization, I wasn't given any prescription medications. My symptoms began to subside on 5/15/2022. I no longer had a fever, though I still had slight chills, head congestion, and fatigue. The fatigue was less severe, so I was able to do some tasks around the house. However, I did still sleep a lot. At the time of this writing, I'm doing pretty well. I have "cotton mouth" and a metallic taste in my mouth, both of which began on 5/15/2022. I still have some congestion, but less of a runny nose. My symptoms are now similar to those of a mild cold.
weight gain; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: WEIGHT INCREASED (non-serious), outcome "unknown", described as "weight gain". Additional information: The patient also reported that she had a lot of side effects and all her symptoms were back (unspecified, as reported).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of an unknown age and gender. On an unknown date, the patients were vaccinated with an improperly stored doses of GARDASIL 9 (route, dose and frequency not reported, lot # reported as M011840, expiration date 01-FEB-2018). The total cumulative temperature excursion was reported as 117 minutes in high temperature (49.1 Fahrenheit) and 225 minutes in low temperature (34.1 Fahrenheit) (the total cumulative time in high and low temperature was reported as 342 minutes). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Angioedema- swelling to left upper lip, sensation of tightness in throat, no visible edema of tongue or posterior pharynx, no difficulty breathing, wheezing, or stridor
Pt recvd MMR/DTP/OPV/HIB vax on 26OCT90 following normal PE; On 01NOV90 pt exp measles like illness w/fever of 102-103, cough, coryza, conjunctivitis & rhinitis; On 04NOV90 fever 103.8, devel reddish macular rash on cheeks & face;
Roughly 12 hours after I recieved my second dose of the vaccine (around 11:00 PM on 3/26) I started to develop a fever, headache, and chills. These symptoms lasted throughout the night into the morning. In the morning on Saturday (3/27), and for most of the day I felt fatigued and slightly nauseous. At 5:00 PM that night, I was walking in the hall of my residence when I experienced a syncopal episode, which has never happened to me before. I fainted several times and my roommate brought me to the ER. Other than low BP, my EKG and other vitals looked fine, and the doctor sent me home with the conclusion it was likley related to the vaccine. The next day, Sunday 3/28, I felt naseua and dizziness all day.
fully vaxed as of 3/15/2021. Admitted to the Hospital on 9/20/2021 at 32 weeks pregnant due to leaking amniotic fluid. Found to be  COVID (+) but asymptomatic.
My adverse reaction begain 1 hr post vaccine with sharp chest pain, dizziness, then headache, blurry vision, and hypertenion. Was 165/107 at highest. Pulse reg 66-88. As RN I managed these symptoms with my heart meds(prn too), ASA 1 tab in eve and one in AM, Tylenol ES at night for headahe, I used complimentary health measures: Frequency Specific Microcurrent a lot and Emotional Freedom Techniques....helped alot. 24 hours after shot still hypertensive but mild 139/96. Angina stopped around mid day 4-10-21.All symptoms were moderate-severe for 20 hrs.  Cont page not working. .Meds: Estradiol, Progresterone,, Valacycolvir prn., Supplements taken: Quercetin/Bromalain, Biotin, Mg, K,
Developed shingles right arm about 10 days after. Is this a contraindication to repeat Hep A?
on the evening on the date of the inj mom noticed quarter size red lump-today 18JUN96 area fifty size-no c/o from pt t100-no soreness;apply ice pack-f/u if sx get worse
episode of vertigo; vomiting; nausea; This is a spontaneous report from contactable physicians (one is the patient). A 41-year-old female patient received the first dose of bnt162b2 (BNT162B2, Solution for injection, lot number: EJ1685), via an unspecified route of administration on the left arm on 22Dec2020 at 12:45 at a single dose for immunization. Medical history included benign paroxysmal positional vertigo, but the patient has not had a flare of this condition in 3.5 years. The patient has no allergies to medications, food, or other products. Concomitant medications were not reported. The patient who has a history of Benign Paroxysmal Positional Vertigo (BPPV) had not had a flare of this condition in 3.5 years. Previously, it has only been brought on by scuba diving, then she woke up the day after receiving the Pfizer COVID 19 vaccine, on 23Dec2020 at 06:30 with an episode of vertigo consistent with prior episodes of BPPV. She has associated nausea and vomiting, and her symptoms mostly resolve with doing home exercises, rest and time. On 29Dec2020, that is day 7 after the vaccine and she still have mild vertigo. She has no fevers, chills, or myalgias. She stated that perhaps it was a coincidence but thought it might be worth reporting, and she fully intend to get the second Pfizer vaccine when available. No treatment was received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19, and since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, and no other medications were received by the patient within 2 weeks of vaccination. The events nausea and vomiting resolved in 2020 while the rest of the events was resolving.
Vaccination received 3:15PM 11/05/21. At 5PM  ? Onset of pronounced fatigue and mild soreness at injection site. 6PM ? Mild to moderate headache, muscle aches, low back pain, knee pain, and diffuse joint pain. 7PM to 10PM ? Onset of fever; very cold with chills; temp ranging from 99.5 -100.3 degrees F.   11/06/21 Sat. 8AM to 10PM - Headache, feeling cold/chilled and feverish, itching, swelling, pain, and redness at injection site. Post nasal drip, low back pain, knee pain, diffuse joint pain; muscle aches and joint pain moderate to severe.  11/07/21 Sun. 8AM-4PM Post nasal drip. Soreness at injection site - moderate. Postnasal drip. Low back pain, knee pain, diffuse joint pain; muscle aches and joint pain mild.   11/08/21 Mon. All symptoms resolved.
got third full dose by mistake and not immunocompromised; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (got third full dose by mistake and not immunocompromised) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (got third full dose by mistake and not immunocompromised). At the time of the report, EXTRA DOSE ADMINISTERED (got third full dose by mistake and not immunocompromised) had resolved.            No concomitant medications were provided.   No treatment medications were provided.
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not reported. On unknown dates, the patients were vaccinated with (Oka/Merck) VARIVAX (dose, anatomical route of vaccination, lot numbers and expiration dates were not provided). It was reported by the registered nurse, that (Oka/Merck) VARIVAX was exposed to a defrost cycle (temperature was not provided). Nonetheless, no adverse effects were reported. No product quality issue was involved. This is one of two reports received from the same reporter. Additional information has been requested.
It was a rash on my abdominal area for about 2 to 2 and half weeks. There was pain, redness, and swollen at the injection site for about 3 weeks. I also been have serve headache ever since I got my vaccine. It took about 2 months for the headaches to go away.
Patient presented to ER with left facial droop, neck numbness. It was noted in the triage note that this "happened earlier today and in the past."
given to patients after those doses had been stored in the freezer; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received Herpes zoster (Shingrix) (batch number L4RD3, expiry date 8th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix dose that had been stored in the freezer, which led to incorrect storage of drug. No more information available at the moment of call. The reporter consented to follow up. This case has been linked with 1 of 7 linked case reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021169172:Same reporter US-GLAXOSMITHKLINE-US2021AMR170441:Same reporter US-GLAXOSMITHKLINE-US2021AMR170442:Same reporter US-GLAXOSMITHKLINE-US2021AMR170444:Same reporter US-GLAXOSMITHKLINE-US2021AMR170446:Same reporter US-GLAXOSMITHKLINE-US2021AMR170445:Same reporter
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.The following information was reported: SWELLING (non-serious), outcome "unknown", described as "Unknown if consumer was experiencing swelling".Additional information: The patient asked if swelling was one of the side effect, 'natural' swelling and stated that the patient was just calling to find that out. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No additional adverse effects; Received an expired dose of VARIVAX; This spontaneous report has been received from a nurse practitioner, concerning a 14 month old female patient.      The patient's concurrent conditions, historical conditions, previous drug reactions, or allergies were not reported. Concomitant therapies included sterile diluent(manufacturer unknown).  On 18-MAR-2020, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) (dose, frequency, and anatomical location not reported) (lot # N027619 has been verified to be valid, expiration date not reported, but upon internal validation established as 04-OCT-2019) for prophylaxis. No additional adverse effect reported.
This non-serious spontaneous case, initially received from other health professional (nurse) on 05-Oct-2018, concerns a female patient of an unspecified age. On an unspecified date, the patient was administered FLUCELVAX QIVc (dose, route of administration, anatomical location, batch number and expiry date: not reported). It was reported that, during the vaccination the syringe leaked and the vaccine ran down the patient's arm, so partial dose was administered. The reporter did not complain about the product and said it was a user error. At the time of this report, no adverse event was reported.
Information has been received from a physician concerning a 12 year old female who on an unspecified dated was vaccinated with the second dose of GARDASIL. The physician reported that the patient developed a milky discharged from the nipples after the second dose of GARDASIL, "about a week ago", approximately 13-SEP-2007. The discharge lasted two days and resolved without any intervention. The patient had received the first injection of GARDASIL without a problem (date unspecified). No other information was available. Additional information has been requested.
Had intense gut reaction, caused diarrhea for a month, colitis and inflammation in the small intestine (confirmed by colonoscopy). Still investigating gallbladder.
On day of shot patient said it made her hyper.  Today (12/17/15) she said that she had tingling around the injection site and now the area below the injection site has a welt that is ~3"x1" as well as another area below the injection site ~ 6"x3" that is numb to touch sensation.
A patient was given a pfizer covid vaccine and fainted after reaching the waiting chair. The patient fainted approximately 5 minutes after receiving the vaccine. She slumped over and hit her head on a post. Patient did have history of seizure disorder and fainting after bloodwork. The EMS were called and arrived to pharmacy after 10 minutes. The paramedics asked the patient questions in regards to her orientation and where-abouts. They checked her blood pressure and pulse. Everything was found to be fine and they released the patient. The patient left for home with her father.
injection site soreness; severe back pain; This is a spontaneous report from a contactable consumer (patient). A 44-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL8982), via an unspecified route of administration into the left arm on 29Jan2021 10:15 AM at a single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date prior to vaccination. The patient's concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283), via an unspecified route of administration into the left arm on 09Jan2021 08:30 AM at a single dose for COVID-19 immunization and experienced injection site soreness. On 30Jan2021, patient experienced injection site soreness and severe back pain. The events were reported as non-serious and the patient was treated with diclofenac 100mg. Outcome of events was recovering.
Numbness around mouth especially at the upper vermillion Dry, peeling skin around eyes The symptoms lasted around 2.5 weeks and went away. The same symptoms returned within 1-2 days after the second COVID-19 vaccine and lasted around 3 weeks.
Day 1: headache, pain at injection site, lumps at injection site Day 2: pain at injection site, lumps at injection site Day 3: itchiness at injection site, lumps at injection site Day 4-6: minor itchiness, 2 dark spots Day 7: itchiness increases Day 8: very itchy, one large lump noticeably different from other arm - tennis ball sized in diameter with border Day 9: very itchy
Tingling in face, arms and legs. Feels like poor circulation - similar to leg falling asleep.
Within a week, my left leg began to have tremors.  Intermittent tripping began.  Headaches and head pressure followed, continuous to this day. Feeling of flulike symptoms without fever became continuous and have not stopped.  By June of 2012, my left leg began dragging.  My legs are still heavy. By 2013, I was completely disabled.  I discussed with many doctors immediately but was dismissed at every conversation.  IT IS NOT a coincidence.  The vaccine is responsible.  The doctors still have no concrete diagnosis.
Pinched Nerve continued post second dose; She was Miserable; Numb Thumb and Forefinge; Excruciating pain in upper left arm/ Shoulder; Soreness Continued post second dose/ Pain; This spontaneous case was reported by a consumer and describes the occurrence of NERVE COMPRESSION (Pinched Nerve continued post second dose), FEELING ABNORMAL (She was Miserable), HYPOAESTHESIA (Numb Thumb and Forefinge), PAIN IN EXTREMITY (Excruciating pain in upper left arm/ Shoulder) and MYALGIA (Soreness Continued post second dose/ Pain) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 025L20A) for COVID-19 vaccination.     The patient's past medical history included Neck pain (A couple of years ago and went through a Physical therapy for posture.). Concurrent medical conditions included Blood pressure abnormal and Thyroiditis. Concomitant products included LOSARTAN, AMLODIPINE and HYDROCHLOROTHIAZIDE for Blood pressure management, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroiditis, ZINC and COLECALCIFEROL (VIT D3) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced NERVE COMPRESSION (Pinched Nerve continued post second dose), FEELING ABNORMAL (She was Miserable), HYPOAESTHESIA (Numb Thumb and Forefinge), PAIN IN EXTREMITY (Excruciating pain in upper left arm/ Shoulder) and MYALGIA (Soreness Continued post second dose/ Pain). On 01-Mar-2021, NERVE COMPRESSION (Pinched Nerve continued post second dose), FEELING ABNORMAL (She was Miserable) and MYALGIA (Soreness Continued post second dose/ Pain) had resolved, HYPOAESTHESIA (Numb Thumb and Forefinge) had not resolved. At the time of the report, PAIN IN EXTREMITY (Excruciating pain in upper left arm/ Shoulder) had resolved with sequelae.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information includes Steroid shot two weeks after the second dose of vaccination.   This case was linked to MOD-2021-019393 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up received on 26-Jul-2021 and included Patient's Demographics, Medical History, Vaccine dose information, Concomitant medications, Treatment medications and Event Pain in extremity were added.
There was an excursion from the freezer,vaccine administered to 118 patients; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from the freezer,vaccine administered to 118 patients) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from the freezer,vaccine administered to 118 patients). On 01-Nov-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (There was an excursion from the freezer,vaccine administered to 118 patients) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 15-Nov-2021: Follow up document received on nov15,contains patient demographics and product information updated
Within 5 minutes of getting vaccine pt felt dizzy, mild SOB, palpitations, throat itchy and scratchy, weak and numbness in tongue. Pt was given water and then epi-pen. Symptoms improved but still felt weak and dizzy and had some shaking. Pt transported to ER via ambulance
Same as the first vaccine shot only longer-lasting:  fever for 100.3 to 100.8, aching body, stiff neck, throat, slight cough. I felt the effects of a slight fever and aching body into the following day on the 3 of March.